PA8462501A1 - Formula de liberacion prolongada - Google Patents
Formula de liberacion prolongadaInfo
- Publication number
- PA8462501A1 PA8462501A1 PA19988462501A PA8462501A PA8462501A1 PA 8462501 A1 PA8462501 A1 PA 8462501A1 PA 19988462501 A PA19988462501 A PA 19988462501A PA 8462501 A PA8462501 A PA 8462501A PA 8462501 A1 PA8462501 A1 PA 8462501A1
- Authority
- PA
- Panama
- Prior art keywords
- prolonged release
- chlorhydrate
- venlafaxine
- offers
- release formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Abstract
LA PRESENTE INVENCION SE RELACIONA CON UNA FORMULA POSOLOGICA Y DOSIS UNITARIA DE LA MISMA, DE CLORHIDRATO DE VENLAFAXINA, UN AGENTE ANTIDEPRESIVO, DE LIBERACION PROLONGADA SOBRE 24 HORAS, QUE OFRECE UN CONTROL MEJOR DE LAS CONCENTRACIONES PLASMATICAS QUE EL DE LAS FORMULAS CONVENCIONALES EN TABLETAS QUE DEBEN ADMINISTRARSE DOS O MAS VECES AL DIA, Y QUE TAMBIEN SE ASOCIA CON UNA INCIDENCIA MENOR DE NAUSEAS Y VOMITOS QUE LAS TABLETAS CONVENCIONALES. EN SU ASPECTO PRIMARIO, ESTA INVENCION OFRECE UN NUCLEO MEJORADO DE LOS ESFEROIDES DE LIBERACION PROLONGADA, QUE COMPRENDE CLORHIDRATO DE VENLAFAXINA Y CELULOSA MICROCRISTALINA, ES DECIR, SIN EL AGREGADO DE HIDROXIPROPILMETILCELULOSA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96432897A | 1997-11-05 | 1997-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8462501A1 true PA8462501A1 (es) | 2000-05-24 |
Family
ID=25508423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA19988462501A PA8462501A1 (es) | 1997-11-05 | 1998-10-30 | Formula de liberacion prolongada |
Country Status (39)
Country | Link |
---|---|
EP (1) | EP1028718B1 (es) |
JP (1) | JP2001521892A (es) |
KR (1) | KR20010031797A (es) |
CN (1) | CN1278165A (es) |
AR (1) | AR014012A1 (es) |
AT (1) | ATE237320T1 (es) |
AU (1) | AU747978B2 (es) |
BG (1) | BG104397A (es) |
BR (1) | BR9813179A (es) |
CA (1) | CA2305242A1 (es) |
CL (1) | CL2004001705A1 (es) |
CO (1) | CO5011060A1 (es) |
CZ (1) | CZ20001659A3 (es) |
DE (1) | DE69813602T2 (es) |
DK (1) | DK1028718T3 (es) |
EA (1) | EA200000487A1 (es) |
EE (1) | EE04577B1 (es) |
ES (1) | ES2196620T3 (es) |
GE (1) | GEP20043198B (es) |
HK (1) | HK1029056A1 (es) |
HR (1) | HRP20000213B1 (es) |
HU (1) | HU225238B1 (es) |
ID (1) | ID26317A (es) |
IL (1) | IL135457A0 (es) |
MA (1) | MA24691A1 (es) |
NO (1) | NO20002126L (es) |
NZ (1) | NZ504460A (es) |
PA (1) | PA8462501A1 (es) |
PE (1) | PE128699A1 (es) |
PL (1) | PL341141A1 (es) |
PT (1) | PT1028718E (es) |
SK (1) | SK6472000A3 (es) |
SV (1) | SV1998000131A (es) |
TR (1) | TR200001232T2 (es) |
TW (1) | TW555568B (es) |
UA (1) | UA77145C2 (es) |
UY (2) | UY25234A1 (es) |
WO (1) | WO1999022724A2 (es) |
ZA (1) | ZA9810081B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60039132D1 (de) * | 1999-04-06 | 2008-07-17 | Sepracor Inc | O-Desmethylvenlafaxin-Succinat |
ATE367153T1 (de) * | 1999-05-20 | 2007-08-15 | Elan Corp Plc | Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme |
IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
BR0214742A (pt) * | 2001-12-05 | 2004-09-14 | Wyeth Corp | Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação |
WO2003050074A1 (en) * | 2001-12-13 | 2003-06-19 | Cadila Healthcare Limited | Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof |
AU2002217373A1 (en) * | 2002-01-03 | 2003-07-15 | Lek Pharmaceutical And Chemical Company D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
AU2003226752A1 (en) * | 2002-03-28 | 2003-10-13 | Synthon B.V. | Venlafaxine base |
US6696496B2 (en) | 2002-03-28 | 2004-02-24 | Synthon Bv | Low water-soluble venlafaxine salts |
AU2003221535A1 (en) | 2002-03-28 | 2003-10-13 | Synthon B.V. | Venlafaxine besylate |
US20030190351A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon Bv | Extended release venlafaxine formulations |
FR2845289B1 (fr) | 2002-10-04 | 2004-12-03 | Ethypharm Sa | Spheroides, procede de preparation et compositions pharmaceutiques. |
CA2415154C (en) * | 2002-12-24 | 2009-06-16 | Biovail Laboratories Inc. | Modified release formulations of selective serotonin re-uptake inhibitors |
DE10350194B4 (de) * | 2003-10-28 | 2005-11-10 | Bioplanta Arzneimittel Gmbh | Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen |
TW200503670A (en) * | 2003-03-28 | 2005-02-01 | Sandoz Ag | Venlafaxine compositions |
DE60307819T2 (de) * | 2003-07-30 | 2007-10-04 | Pharmathen S.A., Pallini | Venlafaxine Hydrochloridformulierungen mit verzögerter Freisetzung |
HUP0303382A2 (hu) * | 2003-10-10 | 2005-08-29 | EGIS Gyógyszergyár Rt. | Venlafaxin-hidroklorid-tartalmú pelletek |
SI1711169T1 (sl) | 2004-02-04 | 2007-10-31 | Alembic Ltd | Obložene minitablete venlafaksin hidroklorida s podaljšanim sproščanjem |
US7776358B2 (en) | 2004-07-22 | 2010-08-17 | Synthon Ip Inc. | Extended release venlafaxine besylate tablets |
WO2007112579A1 (en) * | 2006-04-03 | 2007-10-11 | Isa Odidi | Drug delivery composition |
WO2007129329A2 (en) * | 2006-05-08 | 2007-11-15 | Jubilant Organosys Limited | Extended release pharmaceutical formulation comprising venlafaxine hydrochloride |
CN102772390B (zh) * | 2012-08-16 | 2014-01-08 | 乐普药业股份有限公司 | 一种盐酸文拉法辛缓释胶囊及其制备方法 |
FR3080278B1 (fr) * | 2018-04-11 | 2021-04-30 | Ghs Patents Ltd | Procede de fabrication d'un spheroide de cannabidiol |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
ZA97976B (en) * | 1996-04-05 | 1997-08-18 | Alza Corp | Uniform drug delivery theraphy. |
-
1998
- 1998-03-11 UA UA2000063197A patent/UA77145C2/uk unknown
- 1998-10-30 PA PA19988462501A patent/PA8462501A1/es unknown
- 1998-11-02 MA MA25330A patent/MA24691A1/fr unknown
- 1998-11-03 TW TW086102797A patent/TW555568B/zh not_active IP Right Cessation
- 1998-11-03 JP JP2000518658A patent/JP2001521892A/ja active Pending
- 1998-11-03 DK DK98956487T patent/DK1028718T3/da active
- 1998-11-03 TR TR2000/01232T patent/TR200001232T2/xx unknown
- 1998-11-03 EA EA200000487A patent/EA200000487A1/ru unknown
- 1998-11-03 NZ NZ504460A patent/NZ504460A/xx unknown
- 1998-11-03 AT AT98956487T patent/ATE237320T1/de not_active IP Right Cessation
- 1998-11-03 IL IL13545798A patent/IL135457A0/xx unknown
- 1998-11-03 GE GEAP19985388A patent/GEP20043198B/en unknown
- 1998-11-03 CA CA002305242A patent/CA2305242A1/en not_active Abandoned
- 1998-11-03 EE EEP200000212A patent/EE04577B1/xx not_active IP Right Cessation
- 1998-11-03 EP EP98956487A patent/EP1028718B1/en not_active Revoked
- 1998-11-03 AU AU13003/99A patent/AU747978B2/en not_active Ceased
- 1998-11-03 CO CO98064480A patent/CO5011060A1/es unknown
- 1998-11-03 CN CN98810881A patent/CN1278165A/zh active Pending
- 1998-11-03 PL PL98341141A patent/PL341141A1/xx not_active Application Discontinuation
- 1998-11-03 PT PT98956487T patent/PT1028718E/pt unknown
- 1998-11-03 KR KR1020007004865A patent/KR20010031797A/ko not_active Application Discontinuation
- 1998-11-03 ES ES98956487T patent/ES2196620T3/es not_active Expired - Lifetime
- 1998-11-03 CZ CZ20001659A patent/CZ20001659A3/cs unknown
- 1998-11-03 BR BR9813179-6A patent/BR9813179A/pt not_active Application Discontinuation
- 1998-11-03 DE DE69813602T patent/DE69813602T2/de not_active Revoked
- 1998-11-03 WO PCT/US1998/023338 patent/WO1999022724A2/en not_active Application Discontinuation
- 1998-11-03 HU HU0004287A patent/HU225238B1/hu not_active IP Right Cessation
- 1998-11-03 ID IDW20000834A patent/ID26317A/id unknown
- 1998-11-03 SK SK647-2000A patent/SK6472000A3/sk unknown
- 1998-11-04 PE PE1998001045A patent/PE128699A1/es not_active Application Discontinuation
- 1998-11-04 AR ARP980105563A patent/AR014012A1/es unknown
- 1998-11-04 SV SV1998000131A patent/SV1998000131A/es not_active Application Discontinuation
- 1998-11-04 ZA ZA9810081A patent/ZA9810081B/xx unknown
- 1998-11-05 UY UY25234A patent/UY25234A1/es not_active IP Right Cessation
-
1999
- 1999-09-03 UY UY25692A patent/UY25692A1/es not_active IP Right Cessation
-
2000
- 2000-04-13 HR HR20000213A patent/HRP20000213B1/xx not_active IP Right Cessation
- 2000-04-26 NO NO20002126A patent/NO20002126L/no not_active Application Discontinuation
- 2000-05-04 BG BG104397A patent/BG104397A/xx unknown
- 2000-12-21 HK HK00108358A patent/HK1029056A1/xx not_active IP Right Cessation
-
2004
- 2004-07-06 CL CL200401705A patent/CL2004001705A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8462501A1 (es) | Formula de liberacion prolongada | |
PA8426401A1 (es) | Formula de liberacion prolongada | |
SV1999000148A (es) | Desnaturalizantes para las sales aminas simpaticomimeticas | |
CR9609A (es) | Formulaciones de una sal de bupropion de liberacion modificada | |
PT1121104E (pt) | Novas formulacoes orais de libertacao controlada | |
HN2002000300A (es) | Nuevos derivados de piperazina | |
UY27740A1 (es) | Nuevos compuestos | |
ECSP034830A (es) | Derivados sustituidos de la ciclohexano-1,4- diamina | |
ES2176106B1 (es) | Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral. | |
BRPI0017528B8 (pt) | uso de uma composição contendo sal de cetotifeno | |
AR025046A1 (es) | Inhibidores il-5 no esteroidales, procedimientos e intermediarios para su preparacion y composiciones farmaceuticas que comprenden dichos inhibidores | |
TR200003156T2 (tr) | Bir aktif içerik olarak izomalt içeren terapötik soğuk algınlığına karşı ajan. | |
AR025951A1 (es) | Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados. | |
ES2305567T3 (es) | Formulaciones de tramadol de liberacion sostenida con una eficacia de 24 horas. | |
ES2171669T3 (es) | Composicion farmaceutica que contiene hidrocloruro de tiagabina y su procedimiento de preparacion. | |
BR0210327A (pt) | Microcápsulas para proteção do hálito | |
AR003093A1 (es) | Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion. | |
HN2000000057A (es) | Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano. | |
ECSP982704A (es) | Formula de liberacion prolongada | |
HN2001000119A (es) | S-metil-dihidro -ziprasidona para el tratamiento de trastornos psiquiatricos y oculares. | |
ECSP972046A (es) | Formula de liberacion prolongada | |
BRPI0410710A (pt) | composições e métodos que compreendem compostos de gastrina e seus usos | |
BR0211027A (pt) | Composição cosmética e métodos cosméticos para obtenção de benefìcio desodorante | |
NO20002428D0 (no) | Hudpreparat | |
ES2078727T3 (es) | Composiciones farmaceuticas. |